This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (150)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Timo E. Strandberg, MD; Veikko V. Salomaa, MD; Vesa A. Naukkarinen, MD; Hannu T. Vanhanen, MD; Seppo J. Sarna, PhD; Tatu A. Miettinen, MD

JAMA. 1991;266(9):1225-1229.

Abstract
Objective.
—To investigate the long-term effects of multifactorial primary prevention of cardiovascular diseases (CVD).

Design.
—The 5-year randomized, controlled trial was performed between 1974 and 1980. The subjects and their risk factors were reevaluated in 1985. Posttrial mortality follow-up was continued up to December 31, 1989.

Setting.
—Institute of Occupational Health, Helsinki, Finland, and Second Department of Medicine, University of Helsinki.

Participants.
—In all, 3490 business executives born during 1919 through 1934 participated in health checkups in the late 1960s. In 1974, 1222 of these men who were clinically healthy, but with CVD risk factors, were entered into the primary prevention trial; 612 were randomized to an intervention and 610 to a control group.

Interventions.
—During the 5-year trial, the subjects of the intervention group visited the investigators every fourth month. They were treated with intensive dietetic-hygienic measures and frequently with hypolipidemic (mainly clofibrate and/or probucol) and antihypertensive (mainly β-blockers and/or diuretics) drugs. The control group was not treated by the investigators.

Main Outcome Measures.
—Total mortality, cardiac mortality, mortality due to other causes.

Results.
—Total coronary heart disease risk was reduced by 46% in the intervention group as compared with the control group at end-trial. During 5 posttrial years, the risk factor and medication differences were largely leveled off between the groups. Between 1974 and 1989 the total number of deaths was 67 in the intervention group and 46 in the control group (relative risk [RR], 1.45; 95% confidence interval [Cl], 1.01 to 2.08; P=.048); there were 34 and 14 cardiac deaths (RR, 2.42; 95% Cl, 1.31 to 4.46; P=.001), two and four deaths due to other CVD (not significant), 13 and 21 deaths due to cancer (RR, 0.62; 95% Cl, 0.31 to 1.22; P=.15), and 13 and one deaths due to violence (RR, 13.0; 95% Cl, 1.70 to 98.7; P =.002), respectively. Multiple logistic regression analysis of treatments in the intervention group did not explain the 15-year excess cardiac mortality.

Conclusion.
—These unexpected results may not question multifactorial prevention as such but do support the need for research on the selection and interaction(s) of methods used in the primary prevention of cardiovascular diseases.

(JAMA. 1991;266:1225-1229)

Author Affiliations
From the Second Department of Medicine (Drs Strandberg, Vanhanen, and Miettinen) and Department of Public Health (Dr Sarna), University of Helsinki, Helsinki, Finland; the National Public Health Institute, Helsinki, Finland (Dr Salomaa); and the Jorvi Hospital, Espoo, Finland (Dr Naukkarinen).

Footnotes
Read in part before the International Symposium on Multiple Risk Factors in Cardiovascular Disease, Washington, DC, December 10, 1990.

Reprint requests to Second Department of Medicine, University of Helsinki, SF-00290 Helsinki, Finland (Dr Strandberg).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Types of Dietary Fat and Risk of Coronary Heart Disease: A Critical Review
Hu et al.
J. Am. Coll. Nutr. 2001;20:5-19.
ABSTRACT | FULL TEXT  

The Role of Dietary Fat in Child Nutrition and Development: Summary of an ASNS Workshop
Milner and Allison
J. Nutr. 1999;129:2094-2105.
FULL TEXT  

Systematic review of antihypertensive therapies: Does the evidence assist in choosing a first-line drug?
Wright et al.
CMAJ 1999;161:25-32.
ABSTRACT | FULL TEXT  

The Munster Heart Study (PROCAM) : Total Mortality in Middle-Aged Men Is Increased at Low Total and LDL Cholesterol Concentrations in Smokers but Not in Nonsmokers
Cullen et al.
Circulation 1997;96:2128-2136.
ABSTRACT | FULL TEXT  

Change in Coronary Risk and Coronary Risk Factor Levels in Couples Following Lifestyle Intervention: The British Family Heart Study
Pyke et al.
Arch Fam Med 1997;6:354-360.
ABSTRACT  

Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease
Ebrahim and Smith
BMJ 1997;314:1666-1666.
ABSTRACT | FULL TEXT  

Mortality After 16 Years for Participants Randomized to the Multiple Risk Factor Intervention Trial
Circulation 1996;94:946-951.
ABSTRACT | FULL TEXT  

Multiple Risk Intervention in High-Risk Hypertensive Patients : A 3-Year Ultrasound Study of Intima-Media Thickness and Plaques in the Carotid Artery
Suurkula et al.
Arterioscler. Thromb. Vasc. Bio. 1996;16:462-470.
ABSTRACT | FULL TEXT  

No association between low cholesterol and violent death
Strandberg
BMJ 1995;311:807c-807.
FULL TEXT  

Serum cholesterol concentraions in parasuicide
Gallerani et al.
BMJ 1995;310:1632-1639.
ABSTRACT | FULL TEXT  

Problems With the Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents
Newman et al.
Arch Pediatr Adolesc Med 1995;149:241-247.
ABSTRACT  

Antihypertensive Therapy in Dyslipidemic Men : Effects on Coronary Heart Disease Incidence and Total Mortality
Manttari et al.
Hypertension 1995;25:47-52.
ABSTRACT | FULL TEXT  

Cholesterol and Violent Behavior
Santiago and Dalen
Arch Intern Med 1994;154:1317-1321.
ABSTRACT  

'The Great Debate About Cholesterol': Medical Controversy and the News Media
Lupton
Journal of Sociology 1994;30:334-339.
ABSTRACT  

Total Serum Cholesterol Levels and Mortality Risk as a Function of Age: A Report Based on the Framingham Data
Kronmal et al.
Arch Intern Med 1993;153:1065-1073.
ABSTRACT  

The Lipid Research Clinics Coronary Primary Prevention Trial: Results of 6 Years of Post-Trial Follow-up
The Lipid Research Clinics Investigators
Arch Intern Med 1992;152:1399-1410.
ABSTRACT  

Serum Cholesterol Level and Mortality Findings for Men Screened in the Multiple Risk Factor Intervention Trial
Neaton et al.
Arch Intern Med 1992;152:1490-1500.
ABSTRACT  

Cholesterol and Noncardiac Mortality
Goldstein
JAMA 1992;267:2740-2741.
ABSTRACT  

Long-term Mortality After Primary Prevention for Cardiovascular Disease
Bassler and Bassler
JAMA 1992;267:2183-2183.
ABSTRACT  

Long-term Mortality After Primary Prevention for Cardiovascular Disease
Modest
JAMA 1992;267:2184-2184.
ABSTRACT  

Long-term Mortality After Primary Prevention for Cardiovascular Disease
Holme
JAMA 1992;267:2183-2183.
ABSTRACT  

Long-term Mortality After Primary Prevention for Cardiovascular Disease
Newman et al.
JAMA 1992;267:2183-2184.
ABSTRACT  

Long-term Mortality After Primary Prevention for Cardiovascular Disease
Mogadam
JAMA 1992;267:2184-2185.
ABSTRACT  

A PUZZLING FAILURE OF CARDIAC RISK REDUCTION
JWatch General 1991;1991:1-1.
FULL TEXT  

The Latest Report From Finland: A Lesson in Expectations
Paul and Hennekens
JAMA 1991;266:1267-1268.
ABSTRACT